Pharvaris (PHVS) Change in Cash (2020 - 2026)
Pharvaris (PHVS) posted Change in Cash of -$57.2 million for Q1 2026, down 30.46% on a QoQ basis from -$43.9 million in Q4 2025, and down 40.55% year-over-year from -$96.3 million in Q1 2025.
Pharvaris (PHVS) Change in Cash (2020 - 2026) Analysis & Trends
Pharvaris' Change in Cash history runs 7 years deep, the most recent figure standing at -$57.2 million for Q1 2026.
- Quarterly Change in Cash fell 40.55% year-over-year to -$57.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.6 million (up 111.65% YoY) and the FY2025 annual result came in at $26.4 million, up 120.67% from the prior year.
- Change in Cash was -$57.2 million for Q1 2026 at Pharvaris, down from -$43.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $19647.1 billion in Q2 2023 and bottomed at -$19641.1 billion in Q3 2023.
- A 5-year average of $356.6 million and a median of -$27.1 million in 2023 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 385414451.59% in 2023, while the deepest fall reached 127777546.09% in 2023.
- Pharvaris' Change in Cash stood at -$21.0 million in 2022, then jumped by 1318.07% to $256.0 million in 2023, then tumbled by 114.42% to -$36.9 million in 2024, then fell by 18.81% to -$43.9 million in 2025, then sank by 30.46% to -$57.2 million in 2026.
- Business Quant data shows PHVS's Change in Cash at -$57.2 million in Q1 2026, -$43.9 million in Q4 2025, and $151.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Pharvaris | 2.23 Bn | 1.94 Bn | - | -57.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.23 Mn |
| Dec 31, 2025 | -43.86 Mn |
| Sep 30, 2025 | 151.68 Mn |
| Jun 30, 2025 | -33.94 Mn |
| Mar 31, 2025 | -40.72 Mn |
| Dec 31, 2024 | -36.92 Mn |
| Sep 30, 2024 | -35.78 Mn |
| Jun 30, 2024 | -29.51 Mn |
| Mar 31, 2024 | -25.49 Mn |
| Dec 31, 2023 | 255.96 Mn |
| Sep 30, 2023 | -19,641.07 Bn |
| Jun 30, 2023 | 19,647.11 Bn |
| Mar 31, 2023 | -27.13 Mn |
| Dec 31, 2022 | -21.01 Mn |
| Sep 30, 2022 | -15.37 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Mar 31, 2022 | -20.22 Mn |
| Dec 31, 2021 | -15.09 Mn |
| Sep 30, 2021 | -11.89 Mn |
| Jun 30, 2021 | -13.94 Mn |